Publication | Closed Access

A Biotechnological Method Provides Access to Aggregation Competent Monomeric Alzheimer's 1–42 Residue Amyloid Peptide

Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryProtein FoldingNatural SciencesMedicineMolecular BiologyNeurochemical BiomarkersPeptide ScienceProtein MisfoldingAnalytical UltracentrifugationProteomicsResidue Amyloid Peptide